First installation of a Thermo Fisher Scientific NGS platform in North Africa

28 January 2025 ─  /  Analytical Sciences  by Margaux COUDERT

 

 

Successful installation of the first Thermo Fisher Scientific Next-Generation Sequencing (NGS) platform in North Africa for pre-implantation genetic testing (PGT) “In House” at the El Mawloud Medical Center in Oran, Algeria.

 

The El Mawloud Medical Center, specializing in Reproductive Medicine and Assisted Reproductive Technology (ART), takes a major step forward in enhancing fertility treatments. 👌

 

The integration of this cutting-edge technology optimizes treatments, increases the chances of successful embryo transfers, and reduces the risk of transmitting severe hereditary diseases. A significant advancement for couples facing reproductive challenges, with long-term benefits for both quality of life and healthcare costs.

 

A big thank you to the laboratory team for their warm welcome and trust, especially Dr. Belmahi Nadira and Dr. Mustapha Bachir BENZEGUIR, who are always at the forefront of innovation and passionately dedicated to improving infertility care in Algeria. 🙏

 

Congratulations to our experts Imad Eddine CHERIFI, Mehrez Jammazi, and Meftahi Nedra for the successful installation, supporting our clients in transforming the healthcare landscape in the region. 👏

Read also...

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

23 September 2025

Analytical Sciences

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

HTDS is pleased to announce the signing of a strategic partnership with Oxford Nanopore Technologies, a UK-based company that is a pioneer and globally recognized for its DNA and RNA sequencing solutions. This new agreement allows HTDS to strengthen its portfolio of analytical solutions and offer its customers a breakthrough technology that is transforming genomic and biological research. Oxford Nanopore : a unique technology to analyze lifeWith the mission to enable “the analysis of anything, by anyone, anywhere”, Oxford Nanopore has developed an innovative sequencing technology based on nanopores.This approach provides researchers and industry professionals with real-time, accurate, flexible, and scalable nucleic acid analysis, opening new perspectives in: Plant and animal genomicsAgriculture and food sciencesEnvironmental research and conservationAlready adopted in more than 125 countries, this technology is revolutionizing our understanding of life and accelerating scientific progress. A complete range of solutions tailored to every projectThrough this partnership, HTDS now distributes the entire Oxford Nanopore portfolio, covering all needs, from individual research to large-scale projects:MinION™ : a portable, personal sequencer, ideal for generating rapid data directly in the field or in the lab.GridION™ : a flexible benchtop sequencer, integrating data processing for multiple simultaneous analyses.PromethION™ (P2 Solo, P2 Integrated, PromethION 24) : a high-throughput platform for projects requiring massive volumes of genomic data.ElysION™ : a fully automated solution, from sample preparation to data analysis.In addition to these platforms, Oxford Nanopore provides a complete sequencing ecosystem, including flow cells and sample preparation kits, as well as control and analysis software such as MinKNOW™ and EPI2ME™, making sequencing accessible even to researchers without bioinformatics expertise. HTDS : a trusted partner for your genomics projectsBy partnering with Oxford Nanopore, HTDS reaffirms its commitment to offering its customers the most innovative technologies to meet their scientific and industrial needs.Research laboratories, academic centers, and industry players will now benefit from powerful, scalable, and tailored tools to address today’s challenges in genomics, health, and the environment.